Literature DB >> 18359858

Substrate specificity of human kallikreins 1 and 6 determined by phage display.

Hai-Xin Li1, Bum-Yeol Hwang, Gurunathan Laxmikanthan, Sachiko I Blaber, Michael Blaber, Pavel A Golubkov, Pengyu Ren, Brent L Iverson, George Georgiou.   

Abstract

The human tissue kallikrein (KLK) family contains 15 secreted serine proteases that are expressed in a wide range of tissues and have been implicated in different physiological functions and disease states. Of these, KLK1 has been shown to be involved in the regulation of multiple physiological processes such as blood pressure, smooth muscle contraction, and vascular cell growth. KLK6 is overexpressed in breast and ovarian cancer tissues and has been shown to cleave peptide derived from human myelin protein and Abeta amyloid peptide in vitro. Here we analyzed the substrate specificity of KLK1 and KLK6, by substrate phage display using a random octapeptide library. Consistent with earlier biochemical data, KLK1 was shown to exhibit both trypsin- and chymotrypsin-like selectivities with Tyr/Arg preferred at site P1, Ser/Arg strongly preferred at P1', and Phe/Leu at P2. KLK6 displayed trypsin-like activity, with the P1 position occupied only by Arg and a strong preference for Ser in P1'. Docking simulations of consensus peptide provide information on the identity of the enzyme residues that are responsible for substrate binding. Bioinformatic analysis suggested several putative KLK6 protein substrates, such as ionotropic glutamate receptor (GluR) and synphilin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18359858      PMCID: PMC2271166          DOI: 10.1110/ps.073333208

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

1.  Elucidation of the substrate specificity of the C1s protease of the classical complement pathway.

Authors:  Felicity K Kerr; Grace O'Brien; Noelene S Quinsey; James C Whisstock; Sarah Boyd; Maria Garcia de la Banda; Dion Kaiserman; Antony Y Matthews; Phillip I Bird; Robert N Pike
Journal:  J Biol Chem       Date:  2005-09-16       Impact factor: 5.157

2.  Zyme, a novel and potentially amyloidogenic enzyme cDNA isolated from Alzheimer's disease brain.

Authors:  S P Little; E P Dixon; F Norris; W Buckley; G W Becker; M Johnson; J R Dobbins; T Wyrick; J R Miller; W MacKellar; D Hepburn; J Corvalan; D McClure; X Liu; D Stephenson; J Clemens; E M Johnstone
Journal:  J Biol Chem       Date:  1997-10-03       Impact factor: 5.157

3.  Substrate specificity of human kallikrein 6: salt and glycosaminoglycan activation effects.

Authors:  Pedro Francisco Angelo; Aurelio Resende Lima; Fabiana M Alves; Sachiko I Blaber; Isobel A Scarisbrick; Michael Blaber; Luiz Juliano; Maria Aparecida Juliano
Journal:  J Biol Chem       Date:  2005-12-01       Impact factor: 5.157

4.  1.70 A X-ray structure of human apo kallikrein 1: structural changes upon peptide inhibitor/substrate binding.

Authors:  Gurunathan Laxmikanthan; Sachiko I Blaber; Matthew J Bernett; Isobel A Scarisbrick; Maria Aparecida Juliano; Michael Blaber
Journal:  Proteins       Date:  2005-03-01

5.  Screening for protease substrate by polyvalent phage display.

Authors:  Radislav Sedlacek; Emily Chen
Journal:  Comb Chem High Throughput Screen       Date:  2005-03       Impact factor: 1.339

6.  Enzymatic profiling of human kallikrein 14 using phage-display substrate technology.

Authors:  Loyse M Felber; Carla A Borgoño; Sylvain M Cloutier; Christoph Kündig; Tadaaki Kishi; Jair Ribeiro Chagas; Patrice Jichlinski; Christian M Gygi; Hans-Jürg Leisinger; Eleftherios P Diamandis; David Deperthes
Journal:  Biol Chem       Date:  2005-03       Impact factor: 3.915

7.  Hydrolysis of somatostatin by human tissue kallikrein after the amino acid pair phe-Phe.

Authors:  D C Pimenta; M A Juliano; L Juliano
Journal:  Biochem J       Date:  1997-10-01       Impact factor: 3.857

8.  Characterization of prostate-specific antigen binding peptides selected by phage display technology.

Authors:  Catherine Ferrieu-Weisbuch; Sandrine Michel; Emilie Collomb-Clerc; Catherine Pothion; Gilbert Deléage; Colette Jolivet-Reynaud
Journal:  J Mol Recognit       Date:  2006 Jan-Feb       Impact factor: 2.137

9.  Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells.

Authors:  Manik C Ghosh; Linda Grass; Antoninus Soosaipillai; Georgia Sotiropoulou; Eleftherios P Diamandis
Journal:  Tumour Biol       Date:  2004 Jul-Aug

10.  Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions.

Authors:  S Engelender; Z Kaminsky; X Guo; A H Sharp; R K Amaravi; J J Kleiderlein; R L Margolis; J C Troncoso; A A Lanahan; P F Worley; V L Dawson; T M Dawson; C A Ross
Journal:  Nat Genet       Date:  1999-05       Impact factor: 38.330

View more
  9 in total

Review 1.  Unleashing the therapeutic potential of human kallikrein-related serine proteases.

Authors:  Ioannis Prassas; Azza Eissa; Gennadiy Poda; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2015-02-20       Impact factor: 84.694

2.  Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.

Authors:  Yijing Yu; Ioannis Prassas; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

Review 3.  Functional intersection of the kallikrein-related peptidases (KLKs) and thrombostasis axis.

Authors:  Michael Blaber; Hyesook Yoon; Maria A Juliano; Isobel A Scarisbrick; Sachiko I Blaber
Journal:  Biol Chem       Date:  2010-04       Impact factor: 3.915

4.  Studies of Thioamide Effects on Serine Protease Activity Enable Two-Site Stabilization of Cancer Imaging Peptides.

Authors:  Taylor M Barrett; Xing S Chen; Chunxiao Liu; Sam Giannakoulias; Hoang Anh T Phan; Jieliang Wang; E Keith Keenan; Richard J Karpowicz; E James Petersson
Journal:  ACS Chem Biol       Date:  2020-03-06       Impact factor: 5.100

Review 5.  Natural and synthetic inhibitors of kallikrein-related peptidases (KLKs).

Authors:  Peter Goettig; Viktor Magdolen; Hans Brandstetter
Journal:  Biochimie       Date:  2010-07-06       Impact factor: 4.079

6.  Pharmacological effects of recombinant human tissue kallikrein on bradykinin B2 receptors.

Authors:  Xavier Charest-Morin; Arvind Raghavan; Matthew L Charles; Tadeusz Kolodka; Johanne Bouthillier; Mélissa Jean; Mark S Robbins; François Marceau
Journal:  Pharmacol Res Perspect       Date:  2015-02-10

7.  In silico analyses and global transcriptional profiling reveal novel putative targets for Pea3 transcription factor related to its function in neurons.

Authors:  Başak Kandemir; Ugur Dag; Burcu Bakir Gungor; İlknur Melis Durasi; Burcu Erdogan; Eray Sahin; Ugur Sezerman; Isil Aksan Kurnaz
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

8.  MANTI: Automated Annotation of Protein N-Termini for Rapid Interpretation of N-Terminome Data Sets.

Authors:  Fatih Demir; Jayachandran N Kizhakkedathu; Markus M Rinschen; Pitter F Huesgen
Journal:  Anal Chem       Date:  2021-03-17       Impact factor: 6.986

9.  Synthesis and Structure-Activity Relationships of N-(4-Benzamidino)-Oxazolidinones: Potent and Selective Inhibitors of Kallikrein-Related Peptidase 6.

Authors:  Elena De Vita; Niels Smits; Helma van den Hurk; Elizabeth M Beck; Joanne Hewitt; Gemma Baillie; Emily Russell; Andrew Pannifer; Véronique Hamon; Angus Morrison; Stuart P McElroy; Philip Jones; Natalia A Ignatenko; Nikolas Gunkel; Aubry K Miller
Journal:  ChemMedChem       Date:  2019-11-18       Impact factor: 3.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.